About the Authors

Gregory N. Dietsch

gdietsch@ventirx.com

Affiliation VentiRx Pharmaceuticals, Seattle, WA, United States of America

Hailing Lu

Current address: Immune Design Corporation, Seattle, WA, United States of America

Affiliation Tumor Vaccine Group, Center for Translational Medicine in Women’s Health, University of Washington, Seattle, WA, United States of America

Yi Yang

Affiliation Tumor Vaccine Group, Center for Translational Medicine in Women’s Health, University of Washington, Seattle, WA, United States of America

Chihiro Morishima

Affiliations Tumor Vaccine Group, Center for Translational Medicine in Women’s Health, University of Washington, Seattle, WA, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America

Laura Q. Chow

Affiliation Department of Medicine, University of Washington, Seattle, WA, United States of America

Mary L. Disis

Affiliation Tumor Vaccine Group, Center for Translational Medicine in Women’s Health, University of Washington, Seattle, WA, United States of America

Robert M. Hershberg

Affiliation VentiRx Pharmaceuticals, Seattle, WA, United States of America

Competing Interests

Gregory N. Dietsch and Robert M. Hershberg are both employees and have ownership (shares) in VentiRx Pharmaceuticals, Seattle, WA, United States of America. Gregory N. Dietsch and Robert M. Hershberg have Patent applications (pending and actual) to which the authors are affiliated and from which the authors may benefit. Robert M. Hershberg is a Board Member of VentiRx Pharmaceuticals. Mary L. Disis is a paid consultant for VentiRx Pharmaceuticals, Seattle, WA, United States of America. The association of Gregory N. Dietsch, Robert M. Hershberg and Mary L. Disis with VentiRx Pharmaceuticals does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: GD HL CM LC RH MD. Performed the experiments: GD HL YY CM LC. Analyzed the data: GD HL CM. Contributed reagents/materials/analysis tools: GD HL CM. Wrote the paper: GD HL MD.